
About Catalysts Bio-Technologies Private Limited
Data last updated:
Catalysts Bio-Technologies Private Limited is a private limited company based in Delhi, India. It operates in the industrial enzymes and biochemicals segment of the chemicals and materials sector. It was incorporated on 23 February 2007 and has been in existence for over 19 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U24234DL2007PTC159686. Its GSTIN is 07AADCC0150B3ZG (Delhi). The company holds 8 GST registrations, of which 4 are active.
The company has an authorised share capital of ₹24 Lakh and a paid-up capital of ₹15.3 Lakh. It is led by directors including Munish Madan (Managing Director) and Poonam Madan.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2024. The registered office is at Plot No. 240 Second Floor Functional Industrial Estate Patparganj, Delhi, India – 110092.
As per the financials filed for FY 2024, the company reported a revenue of ₹164.58 Cr, a growth of 5% compared to the previous year. For the same year it recorded a net profit of ₹22.27 Cr (net margin 13.5%) and EBITDA of ₹32.6 Cr (EBITDA margin 19.8%). Revenue has grown at a compounded annual rate (CAGR) of 30% over three years and 24% over five years.
The company has about 86 employees on its provident fund (EPFO) records.
As per MCA filings, the company has open charges of ₹35.99 Lakh and satisfied charges of ₹4.65 Cr on record. Court records list 10 cases involving the company, including 8 filed by the company and 2 filed against it; 2 cases are pending. The company has 8 deals on record (7 secondary share transfers, 1 funding round), with disclosed funding of ₹19 Lakh; the latest was in October 2021. Its 3 peer companies in the Chemicals industry (Enzymes), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products) are compared by revenue, 1 larger and 2 smaller; the largest is Sanzyme Biologics Private Limited with revenue of ₹226.14 Cr. The company has 10 MSME Form 1 returns on record between 2019 and 2024, listing 273 overdue payments to 20 micro and small suppliers.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website thecatalystsgroup.com.
Company details
Contact details
Catalysts Bio-Technologies Private Limited's registered office is in Delhi, Delhi. Its website is thecatalystsgroup.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Social Media
- Registered AddressPlot No. 240 Second Floor Functional Industrial Estate Patparganj, Delhi, India – 110092
- IndustryChemicals and Materials, Industrial Enzymes & Biochemicals
To see the full contact details of Catalysts Bio-Technologies Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Catalysts Bio-Technologies is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Catalysts Bio-Technologies Private Limited, buy the company report.
Financials of Catalysts Bio-Technologies Private Limited
FY 2024 filings availableCatalysts Bio-Technologies Private Limited reported revenue of ₹164.58 Cr (up 5% YoY) for FY 2024.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 24% over five years, including 5% growth in the latest year. EBITDA fell 5% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹32.6 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹22.27 Cr | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 19.8% | ||||
| Net Profit Margin | 13.5% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Catalysts Bio-Technologies Private Limited, buy the company report.
Board of directors of Catalysts Bio-Technologies Private Limited
Catalysts Bio-Technologies has 3 current directors and 8 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Poonam Madan Also directs: Mehakavya Infratech LLP, Naturegen Biotechnologies LLP, Mehakavya Buildwell LLP and 2 more | Director | 18 Apr 2020 | 6 Years 7 Months | Current |
| Om Prakash Shukla | Director | 18 Aug 2021 | 5 Years 3 Months | Current |
| Munish Madan Also directs: Mehakavya Infratech LLP, Naturegen Biotechnologies LLP, Mehakavya Buildwell LLP and 5 more | Managing Director | 23 Feb 2007 | 19 Years 8 Months | Current |
Peer comparison
Catalysts Bio-Technologies Private Limited is compared with the 3 companies closest to it by revenue in the Chemicals industry (Enzymes), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Sanzyme Biologics Private Limited | ₹226.14 Cr (FY 2025) | 15.0% | Hyderabad, Telangana, India | |||
| Catalysts Bio-Technologies Private Limitedthis company | ₹164.58 Cr (FY 2024) | ₹22.27 Cr | 13.5% | 5.0% | Delhi, India | |
| Anthem Cellutions ( India) Private Limited | ₹91.31 Cr (FY 2017) | -11.0% | Bangalore, Karnataka, India | |||
| Amylo Dex Private Limited | ₹60.75 Cr (FY 2025) | 7.0% | Hyderabad, Telangana, India |
To see the full peer comparison of Catalysts Bio-Technologies Private Limited, buy the company report.
Auditor
Catalysts Bio-Technologies Private Limited is audited by RBAS & ASSOCIATES for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| RBAS & ASSOCIATES | FY 2023 | 012704C |
Shareholding
The shareholding of Catalysts Bio-Technologies Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Catalysts Bio-Technologies Private Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 29 Sep 2020 | 100400331 | Axis Bank Limited | ₹17.99 Lakh | Open | |
| 21 Feb 2017 | 100101950 | Hdfc Bank Limited | ₹18 Lakh | Open | |
| 09 Nov 2020 | 100411818 | Hdfc Bank Limited | ₹50 Lakh | Satisfied | |
| 18 Jul 2014 | 10510040 | Hdfc Bank Limited | ₹3.25 Cr | Satisfied | |
| 18 Oct 2010 | 10251194 | Punjab National Bank | ₹90 Lakh | Satisfied |
To see the full charge records of Catalysts Bio-Technologies Private Limited, buy the company report.
Total charge records: 5 View all charges
Deals & funding
Catalysts Bio-Technologies Private Limited has 8 deals on record (7 secondary share transfers, 1 funding round), with disclosed funding of ₹19 Lakh; the latest was in October 2021.
Deals on record (5 of 8)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Oct 2021 | Secondary share transfer | Undisclosed | Buyer: an individual Seller: an individual |
| Mar 2021 | Secondary share transfer | Undisclosed | Buyer: an individual Seller: an individual |
| Sep 2020 | Secondary share transfer | Undisclosed | Buyer: an individual Seller: an individual |
| Jun 2020 | Secondary share transfer | Undisclosed | Seller: an individual |
| Jun 2020 | Secondary share transfer | Undisclosed | Buyer: an individual Seller: an individual |
To see the full deal history of Catalysts Bio-Technologies Private Limited, buy the company report.
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal cases
Catalysts Bio-Technologies Private Limited has 10 court cases on record: 8 filed by Catalysts Bio-Technologies, 2 filed against it. 2 cases are pending and 8 are disposed.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 8 | 2 | 2 |
| High courts | 2 | 0 | 0 |
Cases on record (5 of 10)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Shahdara, Delhi | Civil suit | Filed by the company against Enzycore Bio Solutions P Ltd and 2 others | Disposed |
| District court, New Delhi, Delhi | Civil suit | Filed by the company against Sir Shadi Lal Enterprises Ltd | Disposed |
| District court, Shahdara, Delhi | Commercial suit | Filed by the company against M/S Sangamnath Sugars Pvt. Ltd. | Pending |
| District court, East, Delhi | Cheque dishonour complaint | Filed by the company against an individual | Pending |
| District court, South West, Delhi | Civil suit | Filed against the company by State | Disposed |
To see the full case history of Catalysts Bio-Technologies Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
Catalysts Bio-Technologies Private Limited has 10 MSME Form 1 returns on record between 2019 and 2024, listing 273 overdue payments to 20 micro and small suppliers. Companies must report dues to micro and small suppliers that stay unpaid for more than 45 days in a half-yearly MSME Form 1 return.
Suppliers with reported dues (5 of 20)
| Supplier | Amount due | Due since | Reported on |
|---|---|---|---|
| an individual supplier | |||
| an individual supplier | |||
| Melzer Chemicals Private Limited | |||
| Mittal Containers Private Limited | |||
| Acuro Organics Limited |
To see the full MSME payment records of Catalysts Bio-Technologies Private Limited, buy the company report.
Individuals and sole proprietors among the suppliers are not named.
GST
Catalysts Bio-Technologies has 8 GST registrations: 4 active and 4 cancelled or inactive.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 07AADCC0150B3ZG | Delhi | Active | 04 Feb 2019 |
| 09AADCC0150B1ZE | Uttar Pradesh | Active | 01 Jul 2017 |
| 27AADCC0150B1ZG | Maharashtra | Active | 29 Jan 2019 |
| 36AADCC0150B1ZH | Telangana | Active | 30 Jan 2019 |
To see the full GST registrations and return filing status of Catalysts Bio-Technologies Private Limited, buy the company report.
Recent activity
Catalysts Bio-Technologies Private Limited has 11 board changes on record since 2007: 3 appointments and 8 cessations. The latest: Om Prakash Shukla ceased to be Additional Director on 30 Nov 2021.
11 earlier events are in the company report.
Frequently asked questions
Catalysts Bio-Technologies is an active private limited company based in Delhi, India. The company works in industrial enzymes and biochemicals, within the chemicals and materials industry. It was incorporated on 23 February 2007 (19+ years old) and is registered under CIN U24234DL2007PTC159686.
Catalysts Bio-Technologies has 3 current directors:
- Munish Madan - Managing Director
- Poonam Madan - Director
- Om Prakash Shukla - Director
The latest financial statements of Catalysts Bio-Technologies on record with the MCA are for the year ended 31 March 2024. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Catalysts Bio-Technologies is 07AADCC0150B3ZG, registered in Delhi. The company has 8 GST registrations in all, of which 4 are active and 4 are cancelled or inactive. Other active GSTINs include 09AADCC0150B1ZE (Uttar Pradesh), 27AADCC0150B1ZG (Maharashtra), 36AADCC0150B1ZH (Telangana).
The CIN (Corporate Identification Number) of Catalysts Bio-Technologies is U24234DL2007PTC159686. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Catalysts Bio-Technologies has 10 court cases on record: 8 filed by the company and 2 filed against it. 2 are pending. Most are in the district courts.
Catalysts Bio-Technologies was incorporated on 23 February 2007, making it 19+ years old. It is registered with the Registrar of Companies, Delhi.
Catalysts Bio-Technologies has 8 deals on record (7 secondary share transfers, 1 funding round), with disclosed funding of ₹19 Lakh; the latest was in October 2021.
The peers of Catalysts Bio-Technologies by revenue are Sanzyme Biologics Private Limited, Anthem Cellutions ( India) Private Limited, Amylo Dex Private Limited, all in the Chemicals industry (Enzymes), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Om Prakash Shukla ceased to be Additional Director on 30 Nov 2021. Om Prakash Shukla was appointed as Director on 18 Aug 2021. Munish Madan ceased to be Director on 15 May 2021. Catalysts Bio-Technologies has 11 board changes on record in total.
Catalysts Bio-Technologies has 10 MSME Form 1 returns on record between 2019 and 2024, listing 273 overdue payments to 20 micro and small suppliers. The latest return was filed on 30 Apr 2024.
Catalysts Bio-Technologies can be reached through the website thecatalystsgroup.com. Its registered office is in Delhi, India.

